Connection

Adam Brufsky to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Adam Brufsky has written about Biomarkers, Tumor.
Adam Brufsky
Connection Strength
0.679
Biomarkers, Tumor
  1. Long-term management of patients with hormone receptor-positive metastatic breast cancer: Concepts for sequential and combination endocrine-based therapies. Cancer Treat Rev. 2017 Sep; 59:22-32.
    View in: PubMed
    Score: 0.355
  2. A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence. Sci Rep. 2019 10 16; 9(1):14863.
    View in: PubMed
    Score: 0.104
  3. Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer. Clin Breast Cancer. 2018 12; 18(6):e1239-e1245.
    View in: PubMed
    Score: 0.096
  4. Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors. Mod Pathol. 2017 08; 30(8):1078-1085.
    View in: PubMed
    Score: 0.088
  5. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases. Breast Cancer Res Treat. 2019 Jul; 176(2):321-328.
    View in: PubMed
    Score: 0.025
  6. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases. Arch Pathol Lab Med. 2006 Oct; 130(10):1516-21.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.